Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications
Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 27, 2026
Lipid Nanoparticle-Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 04, 2025
Improved Methods for the Stable Generation of Human Papillomavirus-Driven Head and Neck Cancer Cell Lines.
Journal: Molecular carcinogenesis
Published: July 07, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: July 04, 2025
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts.
Journal: Cancer research communications
Published: June 28, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors.
Journal: Investigational new drugs
Published: March 08, 2025
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 12, 2025
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer.
Journal: The oncologist
Published: January 06, 2025
Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center.
Journal: Frontiers in oncology
Published: December 17, 2024
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.
Journal: NPJ precision oncology
Published: October 17, 2024
Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 02, 2024
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.
Journal: Molecular carcinogenesis
Published: April 23, 2024
Last Updated: 09/26/2026